Base to Base biotech podcast 44: Treating breast cancer and how a CDMO and immuno-oncology company collaborate
Two-faced nanoparticles help antibiotics treat resistant bacteria
Resolve M Therapeutics exits from stealth
New cancer treatment options through expanding ADC payload spectrum
Base to Base biotech podcast 5: Vitalant’s vital role in blood products, and Brainomix gives hope to stroke victims
Base to Base biotech podcast 4: A new class of therapeutics, and biotech hiring in 2025
Base to Base biotech podcast 3: Nanoparticles and Duchenne muscular dystrophy
Canadian university researchers discover new class of antibiotics
Base to Base biotech podcast 2: Opioid alternatives and epiproteomics
Base to Base biotech podcast 1: Osteoboost and Pheast Therapeutics
SXSW announces 2025 pitch competition finalists
LinkGevity secures place in SPACE-H accelerator programme